The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
July 01, 2024
This publication discusses the use of Kyprolis (carfilzomib)— a proteasome inhibitor—for the treatment of myeloma.
April 21, 2023
This publication covers monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
September 02, 2024
The International Myeloma Foundation provides this glossary that defines commonly used multiple myeloma-related terms
June 05, 2024
This publication discusses peripheral neuropathy, which can be a complication of multiple myeloma or its treatments.
March 01, 2024
This publication discusses the use of Ninlaro (ixazomib)—a proteasome inhibitor—for the treatment of myeloma.
with support from:
Johnson & Johnson and Pfizer.